Lung cancer follow-up complicated by pneumonia after pneumococcal vaccination

Patient Info: Anonymized, Male

On 13 December 2016, the patient was home after pneumonia and hospitalization, still on antibiotics and oxygen, while awaiting the final CT interpretation for lung cancer status.

Metastatic lung cancer controlled on AZD9291 clinical trial with tracheal narrowing under review

Patient Info: Anonymized, Male | Stage IV

Metastatic Site: Metastasis mentioned; site not specified in this entry

On 20 November 2016, the patient’s tumor and metastasis appeared controlled on AZD9291 and the disease was not considered progressive, though tracheal narrowing required closer review and earlier follow-up.

Lung cancer on AZD9291 with tumor shrinkage and new suspected iliac bone metastasis

Patient Info: Anonymized, Male | Stage IV

Metastatic Site: Bone: left sacroiliac/iliac region

On 28 August 2016, AZD9291 had reduced the lung mass and stabilized nodes, but CT also showed a new suspected left iliac/sacroiliac bone metastasis requiring MRI workup.

Lung cancer progression with T790M-positive tissue result and AZD9291 trial start

Patient Info: Anonymized, Male | Stage Metastatic/Advanced

Biomarkers: resistance detected in tissue biopsy

On 5 June 2016, CT showed lung tumor progression after afatinib, but a tissue T790M result allowed entry into an AZD9291 clinical trial and treatment had just started.

Lung cancer progression on afatinib with T790M testing for AZD9291 trial eligibility

Patient Info: Anonymized, Male | Stage Metastatic/Advanced

Biomarkers: resistance testing pending

On 14 April 2016, CT showed the right upper-lobe lung tumor had grown despite afatinib/Giotrif, prompting T790M testing and discussion of AZD9291 trial eligibility or radiotherapy.

Lung cancer follow-up with worsening fatigue, cough, chest pain, and CT wait

Patient Info: Anonymized, Male

On 2 April 2016, the patient was waiting for CT results after worsening fatigue, cough, and chest pain, with oncology review scheduled for 12 April.

Lung cancer on afatinib with liquid-biopsy monitoring and CT pending

Patient Info: Anonymized, Male

Biomarkers: Liquid biopsy drawn for resistance monitoring; specific result pending

On 20 March 2016, the patient was continuing afatinib/Giotrif, had blood drawn for liquid-biopsy resistance monitoring, and was waiting for a new CT appointment.

EGFR-mutated NSCLC on Tarceva with CT follow-up pending and future resistance options discussed

Patient Info: Anonymized, Male

Biomarkers: EGFR mutation; T790M resistance discussed as a possible future resistance mechanism

As of December 2015, he was on Tarceva/erlotinib for EGFR-mutated NSCLC, had new cough/chest pain/fatigue, and was waiting for a control CT to clarify whether the tumor remained controlled.

Lung cancer follow-up with hopeful CT results and a treatment respite

Patient Info: Anonymized, Male

As of March 2015, the latest CT was described as encouraging and gave him a period of respite from tests and hospital stress, although ongoing follow-up remained necessary.

Lung cancer on erlotinib with side effects and CT results pending

Patient Info: Anonymized, Male

As of March 2015, he was continuing erlotinib/Tarceva, dealing with side effects and anxiety while waiting for CT results, and receiving support from readers and other patients.

EGFR-mutated NSCLC on Erlotinib/Tarceva with March CT pending

Patient Info: Anonymized, Male

Biomarkers: EGFR mutation; T790M discussed as a possible later resistance mutation

As of February 2015, he was about 1.5 months into Erlotinib/Tarceva for EGFR-mutated NSCLC and was waiting for a March CT to know whether the tumor was controlled.

Lung cancer on Erlotinib/Tarceva with rash, dyspepsia, mouth irritation, and fatigue

Patient Info: Anonymized, Male

As of January 2015, he had been taking Erlotinib/Tarceva for more than 15 days, was managing early side effects, and was waiting for the March CT to show whether tumor growth had stabilized and whether there was metastasis.

Right upper-lobe lung cancer mass in a 66-year-old non-smoker: diagnosis and PET-scan wait story

Patient Info: Anonymized, Male, 60s

On 29 September 2014, the patient was a 66-year-old man with lung cancer and a 4-5 cm right upper-lobe mass, still trying to obtain a PET scan date after about 7 months since diagnosis.